Correlation between the body roundness index and chronic obstructive pulmonary disease: a cross-sectional analysis

体型圆润度指数与慢性阻塞性肺疾病的相关性:一项横断面分析

阅读:2

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide, with abdominal fat, particularly visceral fat, closely associated with its onset and progression. While the lipid accumulation product (LAP) has been linked to COPD risk, it is not sufficient to fully reflect the level of visceral fat. In contrast, the body roundness index (BRI), a more accurate measure of abdominal fat distribution, has not been fully explored in relation to COPD. METHODS: The study used data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018 for a cross-sectional analysis, including 24,873 participants aged over 40 years. Multivariate logistic regression models evaluated the relationship between BRI and COPD. Subsequently, sensitivity analysis, subgroup analysis, restricted cubic spline (RCS) modeling, and threshold effect evaluation were conducted. RESULTS: A multivariate logistic regression analysis showed that, for every 1-unit increase in the BRI, the risk of COPD increased by 5.1% (95% CI: 1.022-1.080; p < 0.001). Sensitivity analysis confirmed this conclusion (AUC(BRL), 0.78745 and AUC (LAP), 0.78675). In addition, the BRI is significantly better than the LAP (OR = 1.001, 95% CI: 1.000-1.001, p = 0.202) in predicting COPD. The restricted cubic spline (RCS) analysis showed a "U-shaped" relationship between the BRI and COPD, and the threshold effect analysis determined the critical point of BRI to be 3.6583. CONCLUSION: This study demonstrates that the body roundness index (BRI) is significantly associated with COPD risk, with a threshold effect observed at a BRI value of 3.6583. A 1-unit increase in the BRI corresponds to a 5.1% higher COPD risk. The BRI proves to be a more accurate indicator of abdominal fat distribution compared to traditional measures such as the lipid accumulation product (LAP), making it a useful tool for early COPD risk assessment and intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。